Collateral for a security interest recorded Feb 27, 2018 (Biodesix, Inc.).

Lapsed Dec 28, 2022 on the fee record · Medium confidence

Computed 20-year base term

Why Medium: A parent in the chain could not be resolved.

Third maintenance fee unpaid; grace period ended.

Held by Biodesix Inc.

Filed Jan 20, 2009 as application 12/321,394 · Granted Dec 28, 2010

Base term, 20 years from filing

Today

Lapsed Dec 28, 2022

2006 2026

Clock starts
Mar 31, 2006

No longer in force
Dec 28, 2022

Granted
Dec 28, 2010

Term would have run to
Mar 31, 2026

base term after the term ends fee events Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

None

Term adjustment

No prosecution delay on this record.

None

Terminal disclaimer

No disclaimer on this record.

2 of 3

Maintenance fees paid

Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.

Family applications on record here

Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

Its term would have run to Mar 31, 2026: its 20-year base term, with no adjustment for prosecution delay. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.

Step	Input	Date after this step	Confidence
Base term, 20 years from filing	Clock starts Mar 31, 2006, when application 11/396,328, the earliest non-provisional in its chain, was filed (this one was filed Jan 20, 2009); a parent in its chain could not be resolved (the next row)	Mar 31, 2026	High confidence
Continuity chain	A parent in the chain could not be resolved	dated from this application's own claim	Medium confidence
Patent term adjustment	None on file	no change	High confidence
Terminal disclaimer cap	None on record	no cap applied	High confidence
Patent term extension	None on file	no change	High confidence
Fee events	2 of 3 maintenance fees paid	lapsed Dec 28, 2022	High confidence
Computed term end	The steps above, in order	Dec 28, 2022	Medium confidence

This family

US 7,736,905	In force Mar 2028	Mar 2028
Application PCT/US2007/007467	PCT application no patent term	no patent term
US 8,024,282	In force Feb 2028	Feb 2028
Application 61/191,927	Provisional application no patent term	no patent term
US 7,858,390	this patent Dec 2022	Dec 2022
US 7,858,389	Term ended no later than Jun 2026	no later than Jun 2026
US 7,867,775	Term ended Mar 2026	Mar 2026
US 7,906,342	Term ended no later than May 2026	no later than May 2026

8 of 20 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.

Recorded	Assignor	Assignee	Conveyance
Mar 2, 2009 Reel 22349, frame 58	Roder, Heinrich; Tsypin, Maxim; Grigorieva, Julia	Biodesix, Inc.	Assignment of Assignor's Interest
Dec 3, 2013 Reel 31751, frame 694	Biodesix, Inc.	Capital Royalty Partners II L.P.; Capital Royalty Partners II - Parallel Fund "a" L.P.; Parallel Investment Opportunities Partners II L.P.	Short-Form Patent Security Agreement
Dec 3, 2013 reel/frame not recorded	Biodesix, Inc.	Capital Royalty Partners II L.P.	Short-Form Patent Security Agreement
Dec 3, 2013 reel/frame not recorded	Biodesix, Inc.	Capital Royalty Partners II - Parallel Fund "a" L.P.	Short-Form Patent Security Agreement
Dec 3, 2013 reel/frame not recorded	Biodesix, Inc.	Parallel Investment Opportunities Partners II L.P.	Short-Form Patent Security Agreement
Feb 5, 2018 Reel 44831, frame 10	Roder, Heinrich; Tsypin, Maxim; Grigorieva, Julia	Biodesix Inc.	Assignment of Assignor's Interest
Feb 23, 2018 Reel 45022, frame 976	Biodesix, Inc.	Innovatus Life Sciences Lending Fund I, LP, as Collateral Agent	Security Interest
Feb 27, 2018 Reel 45450, frame 503	Capital Royalty Partners II L.P.; Capital Royalty Partners II - Parallel Fund "a" L.P.; Parallel Investment Opportunities Partners II L.P.	Biodesix, Inc.	Security Interest
Apr 12, 2018 Reel 45922, frame 171	Capital Royalty Partners II L.P.; Capital Royalty Partners II - Parallel Fund "a" L.P.; Parallel Investment Opportunities Partners II L.P.	Biodesix, Inc.	Corrective Assignment to Correct the Nature of Conveyance Previously Recorded on Reel 045450 Frame 0503. Assignor(S) Hereby Confirms the Release of Security Interest.
Mar 19, 2021 Reel 55657, frame 911	Innovatus Life Sciences Lending Fund I, LP, as Collateral Agent	Biodesix, Inc.	Release of Security Interest
Nov 22, 2022 Reel 61977, frame 919	Biodesix, Inc.	Perceptive Credit Holdings IV, LP	Security Agreement

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

Free plan: 3 watched companies. Pro: unlimited.

Alerts on its grants, lapses and transfers.

Citations

later US patents cite this one

That is above the median of utility patents granted in 2010 in our data, the only group it is compared against. How we rank

Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Selection of Colorectal Cancer Patients for Treatment with Drugs Targeting Egfr Pathway